PCR191 Impact Of Valbenazine On Improvements In Health-Related Quality of Life (HRQoL) In Patients With Tardive Dyskinesia (TD): EQ-5D-5L Results From A Phase 4 Randomized Withdrawal Study (NCT03891862)
Abstract
Authors
Michael Serbin Justin Nedzesky Edward Matson Sarah Gao Morgan Bron Roland Jimenez